ML 351
|
2物価
選択条件:
ブランド
- Sigma-Aldrich Japan
パッケージ
- 5mg
- 25mg
- 生産者Sigma-Aldrich Japan
- 製品番号SML1353
- 製品説明 ≥98% (HPLC)
- 英語製品説明ML351 ≥98% (HPLC)
- 包装単位5mg
- 価格¥36100
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番号SML1353
- 製品説明 ≥98% (HPLC)
- 英語製品説明ML351 ≥98% (HPLC)
- 包装単位25mg
- 価格¥146000
- 更新しました2024-03-01
- 購入
| 生産者 | 製品番号 | 製品説明 | 包装単位 | 価格 | 更新時間 | 購入 |
|---|---|---|---|---|---|---|
| Sigma-Aldrich Japan | SML1353 | ≥98% (HPLC) ML351 ≥98% (HPLC) |
5mg | ¥36100 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | SML1353 | ≥98% (HPLC) ML351 ≥98% (HPLC) |
25mg | ¥146000 | 2024-03-01 | 購入 |
プロパティ
沸点 :507.3±60.0 °C(Predicted)
比重(密度) :1.29±0.1 g/cm3(Predicted)
貯蔵温度 :2-8°C
溶解性 :≤5mg/ml in DMSO;25mg/ml in dimethyl formamide
酸解離定数(Pka) :-0.97±0.10(Predicted)
外見 :powder
色 :white to beige
InChI :1S/C15H11N3O/c1-17-15-13(9-16)18-14(19-15)12-8-4-6-10-5-2-3-7-11(10)12/h2-8,17H,1H3
InChIKey :DYXYXTDIFMDJIR-UHFFFAOYSA-N
SMILES :CNC1=C(C#N)N=C(O1)C2=C3C(C=CC=C3)=CC=C2
比重(密度) :1.29±0.1 g/cm3(Predicted)
貯蔵温度 :2-8°C
溶解性 :≤5mg/ml in DMSO;25mg/ml in dimethyl formamide
酸解離定数(Pka) :-0.97±0.10(Predicted)
外見 :powder
色 :white to beige
InChI :1S/C15H11N3O/c1-17-15-13(9-16)18-14(19-15)12-8-4-6-10-5-2-3-7-11(10)12/h2-8,17H,1H3
InChIKey :DYXYXTDIFMDJIR-UHFFFAOYSA-N
SMILES :CNC1=C(C#N)N=C(O1)C2=C3C(C=CC=C3)=CC=C2
安全情報
| 絵表示(GHS): |
|
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注意喚起語: | Danger | ||||||||||||||||
| 危険有害性情報: |
|
||||||||||||||||
| 注意書き: |
|
説明
Lipoxygenases (LOs) are non-heme iron-containing dioxygenases that catalyze the oxidation of polyunsaturated fatty acids to generate unsaturated fatty acid hydroperoxides. The immediate products of 15-LO fatty acid oxidation act as mediators in inflammation, thrombosis, and cancer. ML351 is an inhibitor of human reticulocyte 15-LO-1 (IC50 = 200 nM) with >250-fold selectivity over the related enzymes 5-LO, platelet 12-LO, 15-LO-2, ovine COX-1, and human COX-2. ML351 was shown to be protective against oxidative glutamate toxicity in mouse neuronal HT-22 cells and significantly reduced infarct size in an in vivo mouse model for ischemic stroke.供給者とメーカー
BOC Sciences
Guangzhou Isun Pharmaceutical Co., Ltd
Sigma-Aldrich
Shanghai Lollane Biological Technology Co.,Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Shanghai YuanYe Biotechnology Co., Ltd.
Tianjin Kailiqi Biotechnology Co., Ltd.
Shanghai Chaolan Chemical Technology Center
Beijing Solarbio Science & Tecnology Co., Ltd.
Angel Pharmatech, Ltd.



